Low-modulus modified bone cement and preparation method thereof
By using silicone modified core/shell materials in bone cement, the elastic modulus is reduced and the compressive strength is improved, the problem of stress occlusion effect of existing bone cement after vertebroplasty is solved, and the vertebral body is realized Effectively support and reduce the risk of fracture.
Patent Information
- Application Number
- CN202411115486.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-14
- Publication Date
- 2024-11-26
AI Technical Summary
The existing bone cement has a high elastic modulus after vertebroplasty, which increases the risk of fractured vertebral bodies and adjacent vertebral bodies. Methods that reduce elastic modulus usually damage compressive strength and cannot effectively support fractures. Vertebral body.
Using low-modulus modified bone cement, including silicone modified core/shell materials, reduces elastic modulus and increases compressive strength to bring it close to human cancellous by introducing -Si-O-bonds and specific molecular chain structures. The elastic modulus of bones is provided while providing sufficient support.
The low elastic modulus and high compressive strength of bone cement are achieved, which reduces the postoperative stress occlusion effect, improves the support capacity of the vertebral body, and reduces the risk of fracture.
Smart Images

Figure SMS_1 
Figure SMS_2
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of bone cement, and particularly relates to low modulus modified bone cement and a preparation method thereof. Background Art
[0002] With the aging of the global population, osteoporosis is becoming increasingly common. Osteoporosis is a bone disease characterized by decreased bone density and damaged bone structure, resulting in more susceptible fractures. The most common form of fracture caused by osteoporosis is osteoporotic vertebral compression fracture (OVCF). Percutaneous vertebroplasty and kyphoplasty are common minimally invasive surgical treatments for OVCF. In clinical practice, polymethyl methacrylate (PMMA) is the most commonly used bone cement. Its good operability and rapid dispersion after injection ensure rapid stabilization of fractures and relief of pain. Patients can walk and move around on the second day, which greatly improves the quality of life of patients and reduces the economic burden on society and families.
[0003] In actual applications, fractures will occur again after vertebroplasty. Studies have shown that reducing the elastic modulus of bone cement may be a way to reduce the stress changes in the fractured vertebra and adjacent vertebrae caused by surgery. The preparation of low-modulus PMMA bone cement has been reported in the literature. The current method that is being studied more is to add pore-forming agents to bone cement to reduce the elastic modulus. However, the increase in porosity also has a negative impact on the compressive strength of bone cement. If the compressive strength is too low, the bone cement will be unable to support the fractured vertebra when stress is applied at the cement-bone interface.
[0004] Therefore, it is of great significance to develop a bone cement with sufficient compressive strength and appropriate elastic modulus to provide adequate support and reduce stress shielding.
[0005] The information disclosed in this background technology section is only intended to enhance the understanding of the overall background of the invention and should not be regarded as an acknowledgment or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art. Summary of the invention
[0006] The purpose of the present invention is to provide a low modulus modified bone cement and a preparation method thereof. The elastic modulus of the bone cement is close to that of human vertebral cancellous bone, and at the same time, it can provide higher compressive strength and help better restore the early vertebral hardness.
[0007] In order to achieve the above object, a technical solution provided by a specific embodiment of the present invention is as follows:
[0008] The low modulus modified bone cement comprises a solid phase and a liquid phase, wherein the solid phase comprises a core / shell material modified by organic silicon, the core material is an organic silicon modified butyl acrylate copolymer, and the shell material is a styrene-acrylonitrile copolymer.
[0009] In one or more embodiments of the present invention, the core material includes 15-40wt% butyl acrylate, 2-20wt% organic silane coupling agent, 0.05-0.1wt% first initiator, 0.5-2wt% emulsifier, and 50-82wt% deionized water.
[0010] In one or more embodiments of the present invention, the organosilane coupling agent is selected from γ-methacryloxypropyl trichlorosilane, γ-methacryloxypropyl trimethoxysilane, γ-methacryloxypropyl methyldiethoxysilane and γ-methacryloxypropyl methyldimethoxysilane;
[0011] and / or, the first initiator is selected from tert-butyl hydroperoxide, cumene hydroperoxide, dicumyl peroxide and di-tert-butyl peroxide;
[0012] And / or, the emulsifier is selected from sodium dodecylbenzene sulfonate, sodium fatty alcohol ether sulfate, sodium stearate methyl polyoxyethylene ether sulfonate and sodium secondary alkyl sulfonate.
[0013] In one or more embodiments of the present invention, the organosilicon-modified core / shell material includes 15-60 wt % of a mixture of styrene and acrylonitrile, 0.08-0.2 wt % of a second initiator, 0.5-10 wt % of deionized water, and the remainder is core material.
[0014] In one or more embodiments of the present invention, in the mixture of styrene and acrylonitrile, the weight ratio of acrylonitrile to styrene is 1:2-5.
[0015] In one or more embodiments of the present invention, the solid phase includes a silicone-modified core / shell material, a developer, a third initiator, and an acrylate polymer in a mass ratio of 5-20:10-50:0.5-2:40-60.
[0016] In one or more embodiments of the present invention, the solid phase has a Si-O-Si network structure.
[0017] In one or more embodiments of the present invention, the liquid phase includes an acrylate monomer, an inhibitor, and an activator in a volume ratio of 95-98:0.1-2:0.1-5.
[0018] In one or more embodiments of the present invention, the acrylate monomer is selected from methyl methacrylate, methyl acrylate and butyl methacrylate;
[0019] and / or, the polymerization inhibitor is selected from hydroquinone, catechol and p-benzoquinone;
[0020] And / or, the activator is selected from N,N-dihydroxyethyl-p-methylaniline and N,N-dimethyl-p-toluidine.
[0021] Another specific embodiment of the present invention provides a technical solution as follows:
[0022] The preparation method of low modulus modified bone cement comprises the following steps:
[0023] According to the proportion, the organosilicon-modified core / shell material, the developer, the third initiator and the acrylic polymer are mixed to obtain a solid phase;
[0024] Mixing the acrylic acid ester monomer, the polymerization inhibitor and the activator according to the proportion to obtain a liquid phase;
[0025] The solid phase and the liquid phase are mixed in proportion to obtain low modulus modified bone cement.
[0026] In one or more embodiments of the present invention, the preparation of the organosilicon-modified core / shell material is as follows:
[0027] According to the proportion, butyl acrylate, organic silane coupling agent, first initiator, emulsifier and deionized water are mixed, the reaction temperature is 50-100° C., and the reaction time is 1-5 hours to obtain a core material;
[0028] The core material, styrene-acrylonitrile mixture, second initiator and deionized water are mixed according to the proportion, polymerized at 50-100° C. for 1-5 hours, cured, washed and dried to obtain the organosilicon-modified core / shell material.
[0029] Compared with the prior art, the bone cement of the present invention has a lower elastic modulus, close to the elastic modulus of human cancellous bone (50-800MPa), and a compressive strength greater than 70MPa, which is sufficient to provide support for the vertebral body and can reduce postoperative complications caused by stress shielding between bone cement and cancellous bone. DETAILED DESCRIPTION
[0030] The specific embodiments of the present invention are described in detail below, but it should be understood that the protection scope of the present invention is not limited by the specific embodiments.
[0031] Unless explicitly stated otherwise, throughout the specification and claims, the term “comprise” or variations such as “include” or “comprising”, etc., will be understood to include the stated elements or components but not to exclude other elements or components.
[0032] Bone cement is a medical material that fills the bone defect in the body and solidifies to fill the bone defect. The effect of bone cement is related to the surrounding bone tissue. As a biomaterial, bone tissue has functional adaptability. The load applied to the bone and the change in bone morphology obey the Wolff law of bone transformation. Specifically, there is a physiological balance between the external load on the bone and the bone tissue. The bone can maintain the internal stress level through its own growth and absorption. Increased stress causes the bone tissue to strengthen, and as the stress decreases, the bone tissue reabsorbs, that is, the growth and absorption of the bone tissue self-adjusts according to the change in external force. The bone responds to the load acting on it. If there is no load, the bone will be absorbed; if the load is normal, it will maintain normal density; if the load is large, the bone will precipitate too much to bear the load; if the load on the bone is too large, the bone will be destroyed.
[0033] Based on this, the re-fracture after vertebroplasty is prone to multiple factors, and the high elastic modulus of bone cement is one of the factors. Studies have shown that the elastic modulus of PMMA bone cement is significantly different from the host bone around the filling position. The elastic modulus of normal bone cement is 2552MPa, which is much higher than the elastic modulus of trabecular bone (100-700MPa). This difference will produce a stress shielding effect (referring to when two or more components with elastic modulus form a loading system, load, stress and strain will be redistributed. The component with higher elastic modulus bears more load, while the component with lower elastic modulus bears less load, and the strain is reduced accordingly. Therefore, the component with higher elastic modulus plays a role in shielding stress and strain, forming a shielding effect), thereby changing stress transmission, resulting in the vast majority of the load being borne by bone cement, and the bone only bearing a part. The bone tissue does not receive the stress it should be subjected to, bone absorption exceeds bone formation, and osteoclast activity and osteoblast apoptosis are increased, which in turn leads to an increased risk of recurrent fracture of the fractured vertebra and fracture of adjacent vertebrae.
[0034] Therefore, starting from the elastic modulus of human cancellous bone (50-800MPa), the present invention explores reducing the elastic modulus of bone cement to approach the elastic modulus of human cancellous bone, while ensuring that the bone cement has a certain compressive strength to support the vertebral body, so that in specific use, the bone cement and the surrounding bone tissue can maintain a balance in load bearing and reduce the occurrence of stress shielding effect.
[0035] A specific embodiment of the present invention provides a low modulus modified bone cement, including a solid phase and a liquid phase, wherein the solid phase includes an organosilicon-modified core / shell material, the core material is an organosilicon-modified butyl acrylate copolymer, and the shell material is a styrene-acrylonitrile copolymer.
[0036] Specifically, the elastic modulus of a high molecular polymer is related to the compliance of the molecular chain. As the compliance increases, the elastic modulus decreases. The compliance of the molecular chain mainly depends on whether the molecular chain can perform internal rotation. The easier the molecular chain rotates, the better the compliance. The side groups of PMMA are methyl and methyl ester groups. The methyl and methyl ester groups are connected to the same carbon atom, which is an asymmetric structure in space, and there is a large steric hindrance, which causes a certain difficulty in the internal rotation of the molecular chain. The present invention adds a core / shell material modified by organosilicon in the solid phase, and forms a Si-O-Si network structure by introducing -Si-O-bonds. On the one hand, -Si-O-bonds have a long bond length, and internal rotation is easy, which can increase the compliance of the molecular chain. On the other hand, organosilicon plays a role of increasing volume, which can promote the adhesion between the raw materials, and can also increase the entanglement of the molecular chain, thereby improving the compressive strength.
[0037] In addition, the core material is a silicone-modified butyl acrylate copolymer, which introduces a butyl ester group. The polarity of the butyl ester group is smaller than that of the methyl ester group, the interaction between the side groups is reduced, and the single bond is easy to rotate, which increases the flexibility of the molecular chain; the shell material is a styrene-acrylonitrile copolymer, which introduces a benzene ring and a cyano group. The benzene ring is a rigid structure that can improve the compressive strength of the polymer. The cyano group, as a polar group, can appropriately increase the intermolecular force, increase the rigidity of the molecular chain, and thus improve the compressive strength of the polymer. The core part of the core / shell structure absorbs external energy to produce deformation, and the shell part plays a stress concentration role, so that PMMA bone cement presents a low modulus and high compressive strength.
[0038] In one embodiment, the core material includes 15-40 wt % of butyl acrylate, 2-20 wt % of an organic silane coupling agent, 0.05-0.1 wt % of a first initiator, 0.5-2 wt % of an emulsifier, and 50-82 wt % of deionized water.
[0039] In one embodiment, the organosilane coupling agent is selected from γ-methacryloxypropyltrichlorosilane, γ-methacryloxypropyltrimethoxysilane, γ-methacryloxypropylmethyldiethoxysilane and γ-methacryloxypropylmethyldimethoxysilane; the first initiator is selected from tert-butyl hydroperoxide, isopropylbenzene hydroperoxide, diisopropylbenzene peroxide and di-tert-butyl peroxide; the emulsifier is selected from sodium dodecylbenzene sulfonate, sodium fatty alcohol ether sulfate, sodium stearate polyoxyethylene ether sulfonate and sodium secondary alkyl sulfonate.
[0040] In one embodiment, the organosilicon-modified core / shell material includes 15-60 wt % of a mixture of styrene and acrylonitrile, 0.08-0.2 wt % of a second initiator, 0.5-10 wt % of deionized water, and the remainder is core material.
[0041] Specifically, in the mixture of styrene and acrylonitrile, the weight ratio of acrylonitrile to styrene is 1:2 to 5. The rigidity of the molecular chain directly affects the compressive strength of the bone cement. The acrylonitrile and styrene are compounded in a specific weight ratio to ensure that the compressive strength of the bone cement is moderate, avoiding damage to the spine due to excessive compressive strength.
[0042] In one embodiment, the second initiator is tert-butyl hydroperoxide, cumene hydroperoxide, dicumyl peroxide, and di-tert-butyl peroxide.
[0043] In one embodiment, the solid phase includes a silicone-modified core / shell material, a developer, a third initiator, and an acrylate polymer in a mass ratio of 5 to 20:10 to 50:0.5 to 2:40 to 60.
[0044] Specifically, the proportion of the organosilicon-modified core / shell material in the solid phase will affect the elastic modulus of the bone cement. Properly increasing the proportion of the organosilicon-modified core / shell material is beneficial to reducing the elastic modulus of the bone cement and at the same time making it have better compressive strength.
[0045] In one embodiment, the developer is selected from barium sulfate and zirconium dioxide. The developer can be used to increase visibility and thus ensure the accuracy of the surgical operation.
[0046] In one embodiment, the third initiator is selected from benzoyl peroxide and tert-butyl benzoyl peroxide.
[0047] In one embodiment, the acrylic polymer is selected from polymethyl methacrylate, styrene-methyl methacrylate copolymer and methyl acrylate-methyl methacrylate copolymer.
[0048] Specifically, the particle size of the acrylic polymer is in the range of 20-200 μm.
[0049] In one embodiment, the liquid phase includes an acrylate monomer, an inhibitor, and an activator in a volume ratio of 95-98:0.1-2:0.1-5.
[0050] In one embodiment, the acrylate monomer is selected from methyl methacrylate, methyl acrylate and butyl methacrylate; the inhibitor is selected from hydroquinone, catechol and p-benzoquinone; and the activator is selected from N,N-dihydroxyethyl-p-methylaniline and N,N-dimethyl-p-toluidine.
[0051] In one embodiment, the mass ratio of the solid phase to the liquid phase is 2 to 3:1.
[0052] Another specific embodiment of the present invention provides a method for preparing low modulus modified bone cement, comprising steps 1-4.
[0053] Step 1, preparing a silicone-modified core / shell material.
[0054] Specifically, the emulsion polymerization method is adopted to mix butyl acrylate, an organic silane coupling agent, an initiator, an emulsifier and deionized water, and polymerize at 50-100° C. for 1-5 hours to obtain a core material; the core material, a styrene-acrylonitrile mixture, an initiator and deionized water are mixed, and polymerize at 50-100° C. for 1-5 hours, and then a magnesium sulfate aqueous solution with a mass concentration of 50-90% is added for curing, and then washed with deionized water, and dried at 60-120° C. for 18-48 hours to obtain a silicone-modified core / shell material.
[0055] Step 2: Mix the organosilicon-modified core / shell material, developer, initiator and acrylic polymer to obtain a solid phase.
[0056] Specifically, the mass ratio of the organosilicon-modified core / shell material, the developer, the third initiator and the acrylic polymer is 5-20:10-50:0.5-2:40-60. After mixing, the solid phase is obtained by sterilization.
[0057] Step 3, mixing the acrylic acid ester monomer, the polymerization inhibitor and the activator to obtain a liquid phase.
[0058] Specifically, the volume ratio of the acrylate monomer, the polymerization inhibitor and the activator is 95-98:0.1-2:0.1-5. After mixing, the mixture is aseptically filtered and filled, and then the liquid phase is obtained by a sterilization process.
[0059] Step 4, mixing the solid phase and the liquid phase in proportion to obtain low modulus modified bone cement.
[0060] Specifically, the mass ratio of the solid phase to the liquid phase is 2 to 3:1.
[0061] The present invention is further described in detail below in conjunction with specific embodiments.
[0062] Example 1
[0063] The low modulus modified bone cement is specifically prepared as follows:
[0064] 60g of γ-methacryloxypropyl trimethoxysilane, 5g of sodium dodecylbenzene sulfonate and 180g of deionized water were pre-mixed and emulsified at 150rpm, and then 12g of sodium dodecylbenzene sulfonate, 400g of butyl acrylate, 2g of tert-butyl hydroperoxide and 2000g of deionized water were added, and polymerization reaction was carried out at 60°C for 3h to obtain the core material. The core material, 495g of styrene, 165g of acrylonitrile, 3g of tert-butyl hydroperoxide and 30g of deionized water were mixed, and polymerization reaction was carried out at 60°C for 4h to obtain latex; 50g of magnesium sulfate was dissolved in 100g of deionized water to obtain a curing agent, and the curing agent was added dropwise to the latex at 85°C for 1h for curing, and then washed with deionized water and dried at 75°C for 24h to obtain a silicone-modified core / shell material.
[0065] 55 g of polymethyl methacrylate, 1.5 g of benzoyl peroxide, 15 g of organosilicon-modified core / shell material and 28.5 g of zirconium dioxide powder were mixed evenly, then packaged in a paper-plastic bag, and sterilized with ethylene oxide to obtain a solid phase.
[0066] 98 ml of methyl methacrylate monomer, 1.9 ml of N,N-dimethyl-p-toluidine and 0.1 ml of hydroquinone were mixed evenly, and the mixture was filled into a liquid bag after aseptic filtration, and sterilized with ethylene oxide to obtain a liquid phase.
[0067] 26 g of solid phase and 10 g of liquid phase were mixed evenly to obtain low modulus modified bone cement.
[0068] Example 2
[0069] The low modulus modified bone cement is specifically prepared as follows:
[0070] 100g of γ-methacryloxypropylmethyldiethoxysilane, 8g of sodium secondary alkyl sulfonate and 200g of deionized water were pre-mixed and emulsified at 150rpm, and then 12g of sodium secondary alkyl sulfonate, 400g of butyl acrylate, 2g of di-tert-butyl peroxide and 1800g of deionized water were added, and polymerized at 60°C for 3h to obtain the core material. The core material, 495g of styrene, 165g of acrylonitrile, 3g of di-tert-butyl peroxide and 30g of deionized water were mixed, and polymerized at 60°C for 4h to obtain latex; 50g of magnesium sulfate was dissolved in 100g of deionized water to obtain a curing agent, and the curing agent was added dropwise to the latex at 85°C for 1h for curing, and then washed with deionized water and dried at 75°C for 24h to obtain a silicone-modified core / shell material.
[0071] 60 g of styrene-methyl methacrylate copolymer, 1 g of benzoyl peroxide, 10 g of organosilicon-modified core / shell material and 29 g of barium sulfate powder were mixed evenly, then packaged in a paper-plastic bag, and sterilized with ethylene oxide to obtain a solid phase.
[0072] 97 ml of methyl methacrylate monomer, 2.5 ml of N,N-dimethyl-p-toluidine and 0.5 ml of p-benzoquinone were mixed evenly, and the mixture was filled into a liquid bag after aseptic filtration, and sterilized with ethylene oxide to obtain a liquid phase.
[0073] 26 g of solid phase and 10 g of liquid phase were mixed evenly to obtain low modulus modified bone cement.
[0074] Example 3
[0075] The low modulus modified bone cement is specifically prepared as follows:
[0076] 60g of γ-methacryloxypropyl trimethoxysilane, 5g of sodium dodecylbenzene sulfonate and 180g of deionized water were pre-mixed and emulsified at 150rpm, and then 12g of sodium dodecylbenzene sulfonate, 400g of butyl acrylate, 2g of tert-butyl hydroperoxide and 2000g of deionized water were added, and polymerization reaction was carried out at 60°C for 3h to obtain the core material. The core material, 495g of styrene, 165g of acrylonitrile, 3g of tert-butyl hydroperoxide and 30g of deionized water were mixed, and polymerization reaction was carried out at 60°C for 4h to obtain latex; 50g of magnesium sulfate was dissolved in 100g of deionized water to obtain a curing agent, and the curing agent was added dropwise to the latex at 85°C for 1h for curing, and then washed with deionized water and dried at 75°C for 24h to obtain a silicone-modified core / shell material.
[0077] 55 g of polymethyl methacrylate, 1.5 g of benzoyl peroxide, 5 g of organosilicon-modified core / shell material and 28.5 g of zirconium dioxide powder were mixed evenly, then packaged in a paper-plastic bag, and sterilized with ethylene oxide to obtain a solid phase.
[0078] 98 ml of methyl methacrylate monomer, 1.9 ml of N,N-dimethyl-p-toluidine and 0.1 ml of hydroquinone were mixed evenly, and the mixture was filled into a liquid bag after aseptic filtration, and sterilized with ethylene oxide to obtain a liquid phase.
[0079] 26 g of solid phase and 10 g of liquid phase were mixed evenly to obtain low modulus modified bone cement.
[0080] Example 4
[0081] The low modulus modified bone cement is specifically prepared as follows:
[0082] 60g of γ-methacryloxypropyl trimethoxysilane, 5g of sodium dodecylbenzene sulfonate and 180g of deionized water were pre-mixed and emulsified at 150rpm, and then 12g of sodium dodecylbenzene sulfonate, 400g of butyl acrylate, 2g of tert-butyl hydroperoxide and 2000g of deionized water were added, and polymerization reaction was carried out at 60°C for 3h to obtain the core material. The core material, 495g of styrene, 165g of acrylonitrile, 3g of tert-butyl hydroperoxide and 30g of deionized water were mixed, and polymerization reaction was carried out at 60°C for 4h to obtain latex; 50g of magnesium sulfate was dissolved in 100g of deionized water to obtain a curing agent, and the curing agent was added dropwise to the latex at 85°C for 1h for curing, and then washed with deionized water and dried at 75°C for 24h to obtain a silicone-modified core / shell material.
[0083] 55 g of polymethyl methacrylate, 1.5 g of benzoyl peroxide, 20 g of organosilicon-modified core / shell material and 28.5 g of zirconium dioxide powder were mixed evenly, then packaged in a paper-plastic bag, and sterilized with ethylene oxide to obtain a solid phase.
[0084] 98 ml of methyl methacrylate monomer, 1.9 ml of N,N-dimethyl-p-toluidine and 0.1 ml of hydroquinone were mixed evenly, and the mixture was filled into a liquid bag after aseptic filtration, and sterilized with ethylene oxide to obtain a liquid phase.
[0085] 26 g of solid phase and 10 g of liquid phase were mixed evenly to obtain low modulus modified bone cement.
[0086] Comparative Example 1
[0087] The commercially available Pan-Star 2 spinal bone cement was used as a comparative example.
[0088] Comparative Example 2
[0089] The low modulus modified bone cement is specifically prepared as follows:
[0090] 12g of sodium dodecylbenzene sulfonate, 400g of butyl acrylate, 2g of tert-butyl hydroperoxide and 2000g of deionized water were polymerized at 60°C for 3h to obtain the core material. The core material, 495g of styrene, 165g of acrylonitrile, 3g of tert-butyl hydroperoxide and 30g of deionized water were mixed and polymerized at 60°C for 4h to obtain latex; 50g of magnesium sulfate was dissolved in 100g of deionized water to obtain a curing agent, and the curing agent was added dropwise to the latex at 85°C for 1h for curing, and then washed with deionized water and dried at 75°C for 24h to obtain the core / shell material.
[0091] 55 g of polymethyl methacrylate, 1.5 g of benzoyl peroxide, 15 g of core / shell material and 28.5 g of zirconium dioxide powder were mixed evenly, then packaged in a paper-plastic bag, and sterilized with ethylene oxide to obtain a solid phase.
[0092] 97 ml of methyl methacrylate monomer, 2.5 ml of N,N-dimethyl-p-toluidine and 0.5 ml of hydroquinone were mixed evenly, and the mixture was filled into a liquid bag after sterile filtration. The liquid phase was sterilized with ethylene oxide.
[0093] 26 g of solid phase and 10 g of liquid phase were mixed evenly to obtain bone cement.
[0094] Comparative Example 3
[0095] The low modulus modified bone cement is specifically prepared as follows:
[0096] 60g of γ-methacryloxypropyl trimethoxysilane, 5g of sodium dodecylbenzene sulfonate and 180g of deionized water were pre-mixed and emulsified at 150rpm, and then 12g of sodium dodecylbenzene sulfonate, 400g of butyl acrylate, 2g of tert-butyl hydroperoxide and 2000g of deionized water were added, and polymerization reaction was carried out at 60°C for 3h to obtain the core material. The core material, 990g of styrene, 165g of acrylonitrile, 3g of tert-butyl hydroperoxide and 30g of deionized water were mixed, and polymerization reaction was carried out at 60°C for 4h to obtain latex; 50g of magnesium sulfate was dissolved in 100g of deionized water to obtain a curing agent, and the curing agent was added dropwise to the latex at 85°C for 1h for curing, and then washed with deionized water and dried at 75°C for 24h to obtain a silicone-modified core / shell material.
[0097] 55 g of polymethyl methacrylate, 1.5 g of benzoyl peroxide, 15 g of organosilicon-modified core / shell material and 28.5 g of zirconium dioxide powder were mixed evenly, then packaged in a paper-plastic bag, and sterilized with ethylene oxide to obtain a solid phase.
[0098] 98 ml of methyl methacrylate monomer, 1.9 ml of N,N-dimethyl-p-toluidine and 0.1 ml of hydroquinone were mixed evenly, and the mixture was filled into a liquid bag after aseptic filtration, and sterilized with ethylene oxide to obtain a liquid phase.
[0099] 26 g of solid phase and 10 g of liquid phase were mixed evenly to obtain low modulus modified bone cement.
[0100] The mechanical properties of the bone cement in each embodiment and each comparative example were tested: at an ambient temperature of 23±1°C, the solid phase and the liquid phase were mixed and stirred in a bone cement mixing bowl at a mass ratio of 2.6:1 for 30 seconds. According to YY 0459 "Acrylic Resin Bone Cement for Surgical Implants", the sample was molded in a stainless steel mold with a diameter of 6 mm and a height of 12 mm. The sample was kept at a constant temperature of 23±1°C for 24 hours and tested using a mechanical testing machine at a crosshead displacement rate of 20 mm / min. The elastic modulus and compressive strength were obtained from the load-displacement curve, and the results are shown in Table 1.
[0101] Table 1 Bone cement mechanical properties test results
[0102]
[0103]
[0104] As can be seen from Table 1, compared with Comparative Examples 1 and 2, the bone cement in the embodiment of the present invention has both a lower elastic modulus and a higher compressive strength, can provide sufficient support, and reduce stress shielding. Although the bone cement in Comparative Example 2 exhibits a higher compressive strength, the core / shell material is not modified with organosilicon, and the elastic modulus of the bone cement is relatively high, far exceeding the modulus range of human vertebral cancellous bone (50-800MPa), and is easily used in surgery to cause stress changes in the fractured vertebra and adjacent vertebrae, resulting in fracture complications.
[0105] In Comparative Example 3, the weight ratio of acrylonitrile to styrene is 1:6. Although the prepared bone cement has a high compressive strength, the elastic modulus is also high. The bone cement of the embodiment of the present invention can take into account both low elastic modulus and high compressive strength, indicating that by limiting the weight ratio of acrylonitrile to styrene, a bone cement with the expected effect can be obtained.
[0106] It will be apparent to those skilled in the art that the present invention is not limited to the details of the exemplary embodiments described above and that the present invention can be implemented in other specific forms without departing from the spirit or essential features of the present invention. Therefore, the embodiments should be considered exemplary and non-restrictive in all respects, and the scope of the present invention is defined by the appended claims rather than the above description, and it is intended that all changes falling within the meaning and scope of the equivalent elements of the claims be included in the present invention.
[0107] In addition, it should be understood that although the present specification is described according to implementation modes, not every implementation mode contains only one independent technical solution. This description of the specification is only for the sake of clarity. Those skilled in the art should regard the specification as a whole. The technical solutions in each embodiment may also be appropriately combined to form other implementation modes that can be understood by those skilled in the art.
Claims
1. Low modulus modified bone cement, characterized in that, It comprises a solid phase and a liquid phase. The solid phase comprises a core / shell material modified by organic silicon. The core material is an organic silicon modified butyl acrylate copolymer, and the shell material is a styrene-acrylonitrile copolymer.
2. The low modulus modified bone cement according to claim 1, characterized in that The core material comprises 15-40 wt % of butyl acrylate, 2-20 wt % of an organic silane coupling agent, 0.05-0.1 wt % of a first initiator, 0.5-2 wt % of an emulsifier, and 50-82 wt % of deionized water.
3. The low modulus modified bone cement according to claim 2, characterized in that The organosilane coupling agent is selected from γ-methacryloxypropyl trichlorosilane, γ-methacryloxypropyl trimethoxysilane, γ-methacryloxypropyl methyldiethoxysilane and γ-methacryloxypropyl methyldimethoxysilane; and / or, the first initiator is selected from tert-butyl hydroperoxide, cumene hydroperoxide, dicumyl peroxide and di-tert-butyl peroxide; And / or, the emulsifier is selected from sodium dodecylbenzene sulfonate, sodium fatty alcohol ether sulfate, sodium stearate methyl polyoxyethylene ether sulfonate and sodium secondary alkyl sulfonate.
4. The low modulus modified bone cement according to claim 1, characterized in that The organosilicon-modified core / shell material comprises 15-60 wt% of a mixture of styrene and acrylonitrile, 0.08-0.2 wt% of a second initiator, 0.5-10 wt% of deionized water, and the remainder is core material.
5. The low modulus modified bone cement according to claim 4, characterized in that: In the mixture of styrene and acrylonitrile, the weight ratio of acrylonitrile to styrene is 1:2-5.
6. The low modulus modified bone cement according to claim 1, characterized in that: The solid phase comprises a core / shell material modified with organic silicon, a developer, a third initiator and an acrylate polymer in a mass ratio of 5 to 20:10 to 50:0.5 to 2:40 to 60.
7. The low modulus modified bone cement according to claim 1, characterized in that The solid phase has a Si-O-Si network structure.
8. The low modulus modified bone cement according to claim 1, characterized in that The liquid phase comprises an acrylate monomer, a polymerization inhibitor and an activator in a volume ratio of 95-98:0.1-2:0.1-5.
9. The method for preparing the low modulus modified bone cement according to any one of claims 1 to 8, characterized in that: The steps include: According to the proportion, the organosilicon-modified core / shell material, the developer, the third initiator and the acrylic polymer are mixed to obtain a solid phase; Mixing the acrylic acid ester monomer, the polymerization inhibitor and the activator according to the proportion to obtain a liquid phase; The solid phase and the liquid phase are mixed in proportion to obtain low modulus modified bone cement.
10. The method for preparing the low modulus modified bone cement according to claim 9, characterized in that: The preparation of the organosilicon-modified core / shell material is as follows: According to the proportion, butyl acrylate, organic silane coupling agent, first initiator, emulsifier and deionized water are mixed, the reaction temperature is 50-100° C., and the reaction time is 1-5 hours to obtain a core material; The core material, styrene-acrylonitrile mixture, second initiator and deionized water are mixed according to the proportion, polymerized at 50-100° C. for 1-5 hours, cured, washed and dried to obtain the organosilicon-modified core / shell material.
